Results 151 to 160 of about 633,124 (253)

Transcriptomic and metabolomic analyses reveal that lobeglitazone ameliorates hepatic steatosis in rats concurrent with regulation of mitochondrial pyruvate metabolism

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 19, Page 5935-5952, October 2026.
Background and Purpose Lobeglitazone is a thiazolidinedione and PPARγ agonist that improves metabolic parameters and hepatic steatosis, but its mechanisms are not fully understood. This study investigated the effects of lobeglitazone on hepatic transcriptomic and metabolic profiles in a rat model of obesity and Type 2 diabetes mellitus.
Hyekyung Yang   +6 more
wiley   +1 more source

Multicentric Asynchronous Endocrine Mucin‐Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the Skin

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 10, Page 901-906, October 2026.
ABSTRACT Endocrine mucin‐producing sweat gland carcinoma (EMPSGC) is an adnexal neoplasm which typically occurs on periorbital skin and demonstrates overlapping histopathologic features with primary mucinous carcinoma of the skin (MCS). Herein, we report a patient who developed five distinct lesions of EMPSGC and MCS over an eight‐year period, some of ...
Ikuko Hirai   +5 more
wiley   +1 more source

Pathological assessment of tumour beds in breast excisions post‐neoadjuvant therapy: a retrospective cohort study

open access: yesHistopathology, Volume 89, Issue 4, Page 650-657, October 2026.
Pathological assessment of post‐neoadjuvant treatment (NAT) breast specimens uses more laboratory resources compared with non‐NAT cases. The highest resource utilization (specimen resampling, number of tissue blocks submitted, pathologist review) occurred when the tumour bed is not grossly identifiable.
Angela Cheng   +4 more
wiley   +1 more source

Breast - Cross Section - Lobular Carcinoma (Labeled)

open access: yes
Lobular carcinoma of ...
Royal College of Surgeons of Ireland (RCSI)
core  

Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2‐negative breast cancer

open access: yesHistopathology, Volume 89, Issue 4, Page 670-686, October 2026.
Short‐course preoperative endocrine therapy induces histopathological and immunophenotypic changes in oestrogen receptor‐positive, HER2‐negative breast cancer. Proliferative response is independently associated with baseline genomic risk (MammaPrint) and progesterone receptor expression.
Claudia Grosse   +8 more
wiley   +1 more source

Metastasis of Invasive Ductal Carcinoma of the Breast to the Uterine Cervix 30 Years Post‐Mastectomy: A Case Report

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 10, October 2026.
ABSTRACT Metastasis of invasive ductal carcinoma of the breast to the uterine cervix is rare, with only one report of a case occurring more than 20 years after the primary surgery. A 69‐year‐old woman presented with abnormal uterine cervical cytology (atypical glandular cells without tumor diathesis) 30 years after undergoing breast cancer surgery ...
Taro Miyake   +6 more
wiley   +1 more source

Pleomorphic lobular carcinoma of the breast: A case report

open access: yes
Pleomorphic lobular carcinoma of the breast is associated with aggressive behavior. CASE: Fine needle aspiration cytology was performed on a breast lump in a 55-year-old woman. The aspirates showed highly pleomorphic, large cells in a dyscohesive pattern,
Gangane, Nitin
core  

Radiologic Findings of Lobular Carcinoma of the Breast

open access: yes, 1997
PURPOSE: To analyze and characterize the radiologic findings of lobular carcinoma of the breast, a carcinoma which is very rare in Korea. MATERIALS AND METHODS: Twelve patients with pathologically proven lobular carcinoma were included in this study ...
유영훈
core  

Changes in the minor salivary glands and ductal carcinoma resulting from induction of oral carcinogenesis. [PDF]

open access: yesJ Mol Histol
Maia CR   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy